RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU892450EA294F60B3

https://w3id.org/ripe/ripe-kg/author/RIPEAU892450EA294F60B3
SubjectPredicateObject
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type node1
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type rdfs:Resource
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type owl:Thing
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type prov:Person
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type foaf:Person
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki owl:sameAs https://semopenalex.org/author/A5079539358
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki foaf:familyName Kouchaki
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki foaf:givenName Ebrahim
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki foaf:name Ebrahim Kouchaki
ripekg:retraction-notice/24578The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/24616Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/28370High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/67433Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/67435Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:retraction-notice/67441The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial ripe:concerns ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:work/10.1002%2Fptr.7791The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial dcterms:creator ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki
ripekg:work/10.1002%2Fptr.7791In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS dcterms:creator ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki